Paweł Kuć
About
In The Last Decade
Paweł Kuć
25 papers receiving 470 citations
Peers
Comparison fields: 5 of 64
- Public Health, Environmental and Occupational Health 187
- Pediatrics, Perinatology and Child Health 167
- Reproductive Medicine 130
- Epidemiology 127
- Obstetrics and Gynecology 112
Countries citing papers authored by Paweł Kuć
This map shows the geographic impact of Paweł Kuć's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paweł Kuć with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paweł Kuć more than expected).
Fields of papers citing papers by Paweł Kuć
This network shows the impact of papers produced by Paweł Kuć. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paweł Kuć. The network helps show where Paweł Kuć may publish in the future.
Co-authorship network of co-authors of Paweł Kuć
This figure shows the co-authorship network connecting the top 25 collaborators of Paweł Kuć. A scholar is included among the top collaborators of Paweł Kuć based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paweł Kuć. Paweł Kuć is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 30 | |
| 3 | 21 | |
| 4 | 7 | |
| 5 | 39 | |
| 6 | 86 | |
| 7 | 35 | |
| 8 | 32 | |
| 9 | Comparison of the second-generation Beckman Coulter IVD and first-generation AnshLabs ELISA assays for anti-Müllerian hormone in patients undergoing IVF treatment. | 4 |
| 10 | 31 | |
| 11 | 39 | |
| 12 | 23 | |
| 13 | 10 | |
| 14 | 1 | |
| 15 | 22 | |
| 16 | 16 | |
| 17 | 3 | |
| 18 | 13 | |
| 19 | [Angiogenesis-prognostic factor in patients with endometrial cancer]. | 6 |
| 20 | Progestins in hormonal replacement therapy and contraception | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.